New Zealand: Evidentiary requirements for statutory declarations made abroad

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

New Zealand: Evidentiary requirements for statutory declarations made abroad

Sponsored by

aj-park.png
evidence

AJ Park explores a recent case which emphasises the importance of submitting reliable evidence in invalidation proceedings, even where proceedings are undefended

In Leiying Zhu v Shanghai Yunzheng Catering Management Co Limited [2021] NZIPOTM 14A, the Intellectual Property Office of New Zealand (IPONZ) again emphasised the importance of submitting reliable evidence in invalidation proceedings (even where proceedings are undefended). 

The decision is a valuable reminder to ensure that declarations made outside New Zealand are executed appropriately and in accordance with New Zealand legislation. 


Background to the decision

Shanghai Yungzheng Catering (the applicant) filed an application to invalidate trade mark registration 1086236 桂满陇 in the name of Leiying Zhu (Zhu) on several grounds, including that use of the trademark by the owner was likely to deceive or confuse because of the applicant’s reputation in the trademark. 

The applicant filed two statutory declarations in support of its application, one provided by a law clerk of the applicant’s solicitors, and the other provided by the applicant’s IP Director (the ‘Fangping declaration’). 


Evidentiary requirements for statutory declarations made outside New Zealand

  • Section 160(1) of the Trade Marks Act 2002 (TMA) provides that evidence in all proceedings must be given by affidavit or statutory declaration.

  • Section 11(1) of the Oaths and Declarations Act 1957 (ODA) provides that a declaration made in a Commonwealth country outside New Zealand should be made before “any person authorised by the law of that country to administer an oath there for the purpose of a judicial proceeding”.

  • Section 11(2) provides that a declaration made in a non-Commonwealth country outside New Zealand should be made before a Commonwealth representative, a judge, a notary public, or a solicitor of the High Court of New Zealand. Commonwealth representatives include ambassadors, commissioners, ministers, and counsellors and any person lawfully acting for such an officer. 

In Disney Enterprises Inc v Monster Energy Company [2014] NZIPOTM 39, the commissioner confirmed that there was no prescribed form for declarations made in other jurisdictions. As long as the person taking the declaration is from one of the approved categories under sections 11(1) and (2), there is a degree of flexibility around the precise form of the document, and the manner in which it can be taken. According to the commissioner, it was parliament’s expectation that it was appropriate to rely on the expertise and reliability of the approved categories of persons to ensure that the declarations were made properly. 


Evidentiary issues with the Fangping declaration

IPONZ identified the following main evidentiary issues with the Fangping declaration: 


  • The statutory declaration was undated;

  • The statutory declaration was not witnessed correctly, as it was unclear what authority the witness had and whether the declaration was witnessed on the same day that the declaration was signed; and

  • The certificate accompanying the declaration certified the authenticity of the declarant’s signature, rather than confirming that the declarant had declared to an authorised person that the contents of the declaration were true. 

A declaration made in a non-Commonwealth country should be made before a Commonwealth representative, a judge, a notary public, or a solicitor of the High Court of New Zealand. The Fangping declaration was made before Zhou Liping (Liping). The declaration did not describe Liping’s role or title, and did not state that Liping belonged to one of the approved categories set out in section 11(2) of the ODA. 

The commissioner emphasised that as long as Liping belonged to one of the approved categories, a simple description of his position or role would have been sufficient. However, because there was no such description on the declaration, the declaration was inadmissible. 

Furthermore, the certificate annexed to the declaration only certified that Fangping’s signature was genuine, and not that Fangping had declared the truth of the contents of the declaration. That this omission can render a declaration inadmissible was confirmed in Aldi Foods Pty Ltd v Giorgio Armani SPA Milan, Swiss Branch Mendrisio [2013] NZIPOTM 45. 


Key takeaways

It is important to submit reliable evidence in invalidation proceedings, even where proceedings are undefended. Statutory declarations made in Commonwealth countries outside New Zealand should be made before a person authorised to administer an oath in that country, while declarations made outside the Commonwealth should be made before a Commonwealth representative, a judge, a notary public, or a solicitor of the High Court of New Zealand. Failure to satisfy these evidentiary requirements could result in the dismissal of an invalidation action that might otherwise have been successful. 

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article